Tampa Firm's Medication Has Enormous Potential As Hepatitis Treatment (Chronic Hepatitis C)

Tampa Firm's Medication Has Enormous Potential As Hepatitis Treatment
The Tampa Tribune - Feb 24 7:50 PM
TAMPA - Digestive disease specialist David Heiman has dozens of chronic hepatitis C patients who do not respond to the drugs now available. Their only hope is a transplant before their liver gives out.Save to My Web

MIGENIX Reports Third Quarter Fiscal Year 2006 Results
[Press Release] PR Newswire via Yahoo! Finance - Mar 08 5:42 AM
MIGENIX Inc. , a clinical-stage developer of drugs for infectious and degenerative diseases, reports financial results for the three and nine months ended January 31, 2006 and an update on its programs:Save to My Web

YOU ARE HERE:
Aidsmap - Feb 17 4:51 AM
Virological response to hepatitis C therapy after four weeks appears to predict who will have a successful response to a full course of treatment in HIV-positive people coinfected with hepatitis C genotypes 1 or 3, according to findings from two studies presented last week at the Thirteenth Conference on Retroviruses and Opportunistic Infections in Denver.Save to My Web

China drugs firm Phynova rallies
ShareCast via Yahoo! UK & Ireland Finance - Feb 27 8:05 AM
Phynova, which develops pharmaceutical drugs mainly derived from medicines applied in clinical use in China, surged ahead on its AIM debut today.Save to My Web

Coley Pharmaceutical Group Reports Fourth Quarter and Full Year 2005 Financial Results
[Press Release] PR Newswire via Yahoo! Finance - Feb 23 5:31 AM
Coley Pharmaceutical Group, Inc. , a biopharmaceutical company discovering and developing a novel class of drug candidates known as TLR Therapeutics, today reported its financial results for the quarter and year ended December 31, 2005.Save to My Web